Collection's Items (Sorted by Submit Date in Descending order): 101 to 120 of 126
| Issue Date | Title | Author(s) |
| Nov-2019 | Violent outcomes in first-episode psychosis: A clinical cohort study | Whiting, Daniel; Lennox, Belinda; Fazel, Seena |
| Oct-2019 | Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin | Lennox, Belinda |
| Sep-2019 | Is adjunctive CBT really effective for schizophrenia? | Reid, Katherine; Medical Trainee |
| Sep-2019 | The weeks before 100 persecutory delusions: the presence of many potential contributory causal factors | Freeman, Daniel; Diamond, Rowan; Bird, Jessica C.; Cernis, Emma; Collett, Nicola; Isham, Louise; Lister, Rachel; Waite, Felicity |
| Sep-2019 | The comments of voices on the appearance of patients with psychosis: ‘the voices tell me that I am ugly’ | Waite, Felicity; Diamond, Rowan; Collett, Nicola; Teale, Ashley-Louise; Bird, Jessica C.; Cernis, Emma; Isham, Louise; Freeman, Daniel |
| Aug-2019 | Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange). | Freeman, Daniel; Lambe, Sinead; Rovira, Aitor; Goodsell, Andrew; Rosebrock, Laina; Geddes, John R; Clark, David M; Waite, Felicity |
| 2019 | The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study | Dahoun, Tarik |
| Jun-2019 | Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis | External author(s) only |
| Jul-2019 | Ketamine for Psychiatric Disorders | McShane, Rupert |
| Feb-2019 | REBT and Psychosis | Jones, Jason |
| Jul-2019 | Disrupted‐in‐schizophrenia 1 functional polymorphisms and D2/D3 receptor availability: A [11C]‐(+)‐PHNO imaging study | Dahoun, Tarik |
| Jul-2019 | In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis | External author(s) only |
| Jul-2019 | Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS) | Broome, Matthew R.; Freeman, Daniel |
| Jun-2019 | Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2) | Lennox, Belinda; Yeeles, Ksenija; Tomei, Giuliano; Pollard, Rebecca; Vincent, Sally-Anne; Shimazaki, Mio |
| Jun-2019 | Measuring Disturbance of the Endocannabinoid System in Psychosis A Systematic Review and Meta-analysis | Cipriani, Andrea; Lennox, Belinda; Godlewska, Beata R |
| Jun-2019 | Clozapine-induced pericarditis: an ethical dilemma | Johal, Harleen Kaur; Barrera, Alvaro |
| May-2019 | Cognitive Behavioural Therapy for Nightmares for Patients with Persecutory Delusions (Nites): An Assessor-Blind, Pilot Randomized Controlled Trial | Sheaves, Bryony; Waite, Felicity; Harrison, Paul J; Freeman, Daniel |
| 3-May-2019 | Hebephrenia is dead, long live hebephrenia, or why Hecker and Chaslin were on to something | Barrera, Alvaro; Curwell-Parry, Owen |
| Jan-2019 | Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: study protocol for a single-blind parallel-group randomised controlled trial (THRIVE) | Freeman, Daniel; Lister, Rachel; Waite, Felicity |
| 11-Jun-2018 | Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1) | Lennox, Belinda; Tomei, Giuliano; Vincent, Sally-Anne; Yeeles, Ksenija; Pollard, Rebecca |
Collection's Items (Sorted by Submit Date in Descending order): 101 to 120 of 126
